UNSPSC 85818910: Transfusion of autologous hematopoietic stem cells into central vein, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of autologous hematopoietic stem cells into central vein, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30243Y0

UNSPSC 85818910 Transfusion of autologous hematopoietic stem cells into central vein, percutaneous approach is a Commodity code that shows no recent state and local procurement activity aligned with its clinical scope. The six recent opportunities posted under this code between July and September 2026 involve independent medical evaluations for public-safety disability determinations, surgical benefit carve-out programs, occupational medical surveillance, emergency and specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve autologous stem cell transfusions or the specialized cellular procedures the code describes. The mismatch suggests either mis-tagging by issuing bodies or a significant disconnect between the code's nominal clinical scope and actual state and local purchasing patterns under this designation.

The opportunities that do appear under the code span multiple issuing bodies and states: the City of Phoenix Retirement Office (Arizona), the City of Long Beach (California), the Washington State Department of Transportation's ferries division, Harris County Juvenile Probation Department (Texas), Collier County Board of County Commissioners (Florida), and the County of Santa Clara Health System (California). Geographic activity clusters in California, Texas, Arizona, Washington, and Florida. The solicitations range from specialized occupational health surveillance (WSDOT with proposals due October 9, 2026) to broad health-services staffing pools (Santa Clara County with proposals due October 7, 2026) and represent health-care administration, benefits management, and workforce sourcing rather than direct clinical procedure delivery. Unless state and local procurement offices are systematically misapplying this code to health-services contracting broadly, the code presents minimal pursuit opportunity for vendors focused on stem cell therapies or related cellular medicine.